Established in 2022, this GMP manufacturer is a CTD dossier owner and manufacturer, distributing products across multiple countries and regions worldwide. Specializing in various therapeutic categories, including NSAIDs, metabolic syndrome, hematology, CNS, urogenital, antineoplastic, antiviral, opioid medications, and nutraceutical supplements, it operates advanced production lines adhering to international GMP standards. As a CTD dossier owner and manufacturer, it maintains a dynamic team of experts committed to innovation and excellence in the pharmaceutical industry. This GMP manufacturer, as a CTD dossier owner and manufacturer, continues to expand its global presence.